# Adherence in Topical Treatment of Psoriasis

> **NCT02858713** · PHASE4 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 134 (actual)

## Conditions studied

- Adherence

## Interventions

- **DRUG:** Calcipotriene + Betamethasone Dipropionate
- **DEVICE:** App

## Key facts

- **NCT ID:** NCT02858713
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-09
- **Primary completion:** 2017-04-29
- **Final completion:** 2017-08-29
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2019-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02858713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02858713, "Adherence in Topical Treatment of Psoriasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02858713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*